UBC Faculty Research and Publications

Comparative effectiveness of proton pump inhibitors Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 99 reviews the comparative effectiveness of proton pump inhibitors. Conclusions: There is currently no convincing RCT evidence that one PPI is preferable to another for the management of GERD or PUD related symptoms or for endoscopically confirmed healing of esophagitis. The risk of bias assessment of the 63 included RCTs indicated a high risk of selection, reporting, performance and detection bias. There are no long-term, head-to-head comparative RCTs specifically designed to monitor adverse effects of PPIs. Observational studies suggest that long-term use of PPIs is associated with a number of serious adverse effects. The cost of different PPIs vary by over tenfold.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International